We are live on
!
Find out more
MCMC
Matrix Capital Management Company Portfolio holdings
AUM
$46.3M
1-Year Est. Return
114.38%
This Fund
S&P 500
This Quarter
Est. Return
+22.75%
1 Year Est. Return
+114.38%
3 Year Est. Return
+245.06%
5 Year Est. Return
+259.19%
10 Year Est. Return
+1,887.32%
AUM
$46.3M
AUM Growth
-$11.3M
(-20%)
Cap. Flow
-$19.9M
Cap. Flow
% of AUM
-42.94%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MAZE
Maze Therapeutics
MAZE
|
+$19.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
No holdings matched the selected filter criteria.
Similar funds
CM
RRC
FCM
PCM
EGI
IPHI
SM
CG
Matrix Capital Management Company's Q1 2026 Portfolio in Review
As of Q1 2026, Matrix Capital Management Company held 2 positions worth $46.3M, down 20% from $57.6M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Matrix Capital Management Company withdrew a net $19.9M in Q1 2026, closing 1 position. Its most notable exit was Maze Therapeutics, an estimated $19.9M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Matrix Capital Management Company fully exited Maze Therapeutics in Q1 2026, selling an estimated $19.9M.
- Matrix Capital Management Company's ten largest holdings make up 100% of its $46.3M portfolio in Q1 2026.
- Matrix Capital Management Company opened 0 new positions and closed 1 in Q1 2026.
- Matrix Capital Management Company's portfolio value fell 20% quarter-over-quarter to $46.3M.
Based on Matrix Capital Management Company's 13F filing for Q1 2026, filed 14 May 2026.